Publisher： Bentham Science Publishers
E-ISSN： 1873-4316|13|12|2388-2402
ISSN： 1389-2010
Source： Current Pharmaceutical Biotechnology, Vol.13, Iss.12, 2012-09, pp. : 2388-2402
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Neurodegenerative disorders (NDs) are rapidly increasing as population ages. However, successful treatments for NDs have so far been limited and drug delivery to the brain remains one of the major challenges to overcome. There has recently been growing interest in the development of drug delivery systems (DDS) for local or systemic brain administration. DDS are able to improve the pharmacological and therapeutic properties of conventional drugs and reduce their side effects. The present review provides a concise overview of the recent advances made in the field of brain drug delivery for treating neurodegenerative disorders. Examples include polymeric micro and nanoparticles, lipidic nanoparticles, pegylated liposomes, microemulsions and nanogels that have been tested in experimental models of Parkinson's, Alzheimer's and Hungtinton's disease. Overall, the results reviewed here show that DDS have great potential for NDs treatment.
Related content
By Jiang Xinguo
Pharmaceutical Research, Vol. 30, Iss. 10, 2013-10 ,pp. :
Access to resources
Recommend
Drug Delivery Systems for Brain Tumor Therapy
Current Pharmaceutical Design, Vol. 10, Iss. 12, 2004-05 ,pp. :
Perspectives on Brain-Targeting Drug Delivery Systems
Current Pharmaceutical Biotechnology, Vol. 13, Iss. 12, 2012-01 ,pp. :